[1] Shaw RJ,Lamia KA,Vasquez D,et al.The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin[J].Science,2005,310(5754):1642-1646 [2] Jin XM.Effects of metformin on ventricular remodeling in patients with primary hypertension and type 2 diabetes mellitus[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2016,13(1):9-12. [3] Snima KS,Pillai P,Cherian AM,et al.Anti-diabetic drug metformin:challenges and perspectives for cancer therapy[J].Current Cancer Drug Targets,2014,14(8):727-736. [4] Decensi A,Puntoni M,Goodwin P,et al.Metformin and Cancer risk in diabetic patients:a systematic review and meta-analysis[J].Cancer Prevention Research,2010,3(11):1451-1461. [5] Michael WC.Understanding and preventing (N-Nitrosodi-methylamine) NDMA contamination of medications[J].The Annals of Pharmacotherapy,2020,54(6):611-614. [6] George J,Rao KR,Stern R,et al.Dimethylnitrosamine-induced liver injury in rats:the early deposition of collagen[J].Toxicology,2001,156(2):129-138. [7] Ahmad R,Ahmad S,Khan NV,et al.Opercullina turpethum attenu-ates N-nitrosodimethylamine induced toxic liver injury and clastoge-nicity in rats[J].Chemico-Biological Interactions,2009,181(2):145-153. [8] George J,Rao KR,Stern R,et al.Dimethylnitrosamine-induced liver injury in rats:the early deposition of collagen[J].Toxicology,2001,156(2&3):129-138. [9] Gushgari AJ,Halden RU.Critical review of major sources of human exposure to N-nitrosamines[J].Chemosphere,2018,210:1124-1136. [10] Kocak D,Ozel MZ,Gogus F,et al.Determination of volatile nitrosamines in grilled lamb and vegetables using comprehensive gas chromatography-nitrogen chemiluminescence detection[J].Food Chemistry,2012,135(4):2215-2220. [11] Park JE,Seo JE,Lee JY,et al.Distribution of seven N-nitrosamines in food[J].Toxicol Research,2015,31(3):279-288. [12] Lim DS,Roh TH,Kim MK,et al.Risk assessment of N-nitro-sodiethylamine (NDEA) and N-nitrosodiethanolamine (NDELA) in cosmetics[J].Journal of Toxicol Environmental Health A,2018,81(12):465-480. [13] Liteplo RG,Meek ME,Windle W.Concise international chemical asses-sment document 38-N-nitrosodimethylamine[EB/OL].(2002-01-01)[2020-11-01].https://www.who.int/ipcs/publications/cicad/en/cicad38.pdf. [14] Tricker AR,Preussmann R.Carcinogenic N-nitrosamines in the diet:occurrence,formation,mechanisms and carcinogenic potential[J].Mutation Research,1991,259(3-4):277-289. [15] Pottegard A,Kristensen KB,Ernst MT,et al.Use of N-nitro-sodimethylamine (NDMA) contaminated valsartan products and risk of cancer:Danish nationwide cohort study[J].BMJ,2018,362:k3851. [16] Charoo NA,Ali AA,Buha SK,et al.Lesson learnt from recall of valsartan and other angiotensin II receptor blocker drugs containing NDMA and NDEA impurities[J].AAPS Pharm Sci Tech,2019,20(5):166-172. [17] Parr MK,Joseph JF.NDMA impurity in valsartan and other pharmaceutical products:analytical methods for the determination of N-nitrosamines[J].J Pharm Biomed Anal,2019,164:536-549. [18] Jensen,K.FDA calls generic Zantac carcinogen levels "unacc-eptable," but pushes back againstlabclaims.[EB/OL].(2019-10-25)[2020-11-01].https://www.biopharmadive.com/news/fda-valisure-generic-zantac-unacceptable-ndma-carcinogen-levels/564295/. [19] FDA.FDA updates and press announcements on NDMA in metformin[EB/OL].(2020-04-10)[2020-11-01].https://www.fda.gov/drugs/Drug-safety-and-availability-fda-updates-and-press-announcements-ndma-metformin. [20] FDA.GC/MS headspace method for detection of NDMA in valsartan drug substance[EB/OL].[2020-11-01].https://www.fda.gov/downloads/Drugs/DrugSafety/UCM618053.pdf. [21] The general european OMCL network.HS GC-MS method for the determination of NDMA and NDEA in Sartan[EB/OL].(2020-04-10)[2020-11-01] https://www.edqm.eu/sites/default/files/medias/fichiers/Sartans/de-by-gc-ms.pdf. [22] Alshehri YM,Alghamdi TS,Aldawsari FS.HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products[J].J Pharm Biomed Anal.2020,191:113582-113586. [23] Combined direct injection N-Nitrosodimethylamine (NDMA),N-Nitrosodiethylamine (NDEA),N-Nitrosoethylisopropylamine (NEIPA),N-Nitrosodiisopropylamine (NDIPA),N-Nitroso-dibutylamine (NDBA) Impurity Assay by GC-MS-MS[EB/OL].(2019-04-19)[2020-11-01].https://www.fda.gov/media/123409/download. [24] Health canada.Determination of N-nitrosodimethylamine (NDMA) andN-nitrosodiethylamine (NDEA) by GC-MS-MS (Direct Injection) in sartan finished products and drug substances[EB/OL].(2020-04-10)[2020-11-01].https://www.canada.ca/en/health-canada/services/drugs-healthproducts/compliance-enforcement/information-healthproduct/drugs/angiotensin-receptor-blocker.html. [25] The general european OMCL Network.LC-MS-MS method for the determination of NDEA and NDMA in valsartan,Irbesartan and losartan APIs and finished dosage form[EB/OL].(2020-04-10)[2020-11-01].https://www.edqm.eu/sites/default/files/medias/fichiers/Sartans/de-by-lc-msls.pdf. [26] SÖrgel F,Kinzig M,Abdel-Tawab M,et al.The contamination of valsartan and other sartans,part 1:new findings[J].J Pharm biomed Anal,2019,192:395-405. [27] US FDA.RapidFire-MS-MS method,A method that can detect NEIPA,NDIPA,NDBA,NMBA[EB/OL].(2019-07-24)[2020-11-01].https://www.fda.gov/media/125477/download. [28] US FDA.LC-HRMS method a method that can detect NDMA,NDEA,NEIPA,NDIPA,NDBA,NMBA[EB/OL].(2019-05-21)[2020-01-11].https://www.fda.gov/media/125478/download. [29] FDA.Liquid chromatography-high resolution mass spectrometry (LC-HRMS) method for the determination of NDMA in ranitidine drug substance and drug product[EB/OL].(2019-09-13)[2020-11-01].https://www.fda.gov/media/130801/download. [30] EDQM.Ph.Eur.launches a public consultation on a new general chapter for the analysis of N-nitrosamines[EB/OL].(2020-04-07)[2020-11-01].https://www.edqm.eu/en/news/ph-eur- launches-public-consultation-new-general-chapter-analysis-n-nitrosamines. [31] Lim HH,Oh YS,Shin HS.Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans,metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry[J].J Pharm Biomed Anal,2020,189(10):113460. [32] Chen M,The application of HRMS for quality safety control and composition analysis of traditional chinese medicine[D].Beijing:Beijing University of Chinese Medicine,2019. [33] Yang J,Marzan TA,Ye W,et.al.A cautionary tale:quantitative LC-HRMS analytical procedures for the analysis of N-nitroso-dimethylamine in metformin[J].AAPS Journal,2020,22(4):89-97. [34] National Medical Products Administration.Chinese Pharmacopoeia (2020 edition)four volumes[S].Beijing:China Medical Science and Technology Press,2020. [35] Center for Drug Evaluation,National Medical Products Admin-istration.Technical guidelines for research on nitrosamine impurities in chemical drugs (Trial)[S/OL].( 2020-05-08)[2020-11-01].http://www.cde.org.cn. |